[Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides]

Jpn J Antibiot. 1982 Sep;35(9):2314-7.
[Article in Japanese]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Aminoglycosides / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Cefmenoxime
  • Cefotaxime / analogs & derivatives
  • Cefotaxime / pharmacology*
  • Cefsulodin
  • Ceftizoxime
  • Cephalosporins / pharmacology
  • Cephamycins / pharmacology
  • Drug Resistance, Microbial
  • Moxalactam
  • Pseudomonas aeruginosa / drug effects*
  • Serratia marcescens / drug effects*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Cephalosporins
  • Cephamycins
  • Ceftizoxime
  • Cefmenoxime
  • Cefotaxime
  • Cefsulodin
  • Moxalactam